Related Experiment Video

Updated: May 19, 2026

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
08:32

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models

Published on: March 1, 2015

Clinical efficacy and randomized clinical trials in dysphagia

Jeri A Logemann

    International Journal of Speech-Language Pathology
    |September 5, 2012
    PubMed

    Insights

    Research on swallowing disorder treatments needs more large-scale trials. Dose-response studies are lacking for dysphagia, and clinical pressures affect patient care. A clinical trials group can aid future research.

    Area of Science:

    • Speech and Hearing Sciences
    • Clinical Medicine
    • Medical Research

    Background:

    • Current research on treatment efficacy for swallowing disorders lacks large-scale randomized multi-institutional trials.
    • Dose-response trials, crucial for determining optimal treatment levels in dysphagia, are not yet available.
    • Financial and medical pressures on clinicians impact the timely diagnosis and treatment of dysphagia.

    Purpose of the Study:

    • To review the current state of research on treatment efficacy for swallowing disorders.
    • To highlight the need for large-scale randomized multi-institutional trials in dysphagia research.
    • To describe the integration of treatment techniques into diagnostic studies for rapid patient improvement.

    Main Methods:

    • Review of current literature on swallowing disorder treatment efficacy.
    • Discussion of the challenges in conducting clinical trials for dysphagia.
    • Description of the integration of treatment into diagnostic procedures like Modified Barium Swallow (videofluoroscopy).

    Main Results:

    • There is a significant gap in dose-response data for dysphagia treatments.
    • Clinical pressures can compromise the ideal timing of patient care.
    • The integration of treatment into diagnostic studies is a strategy for immediate patient benefit.

    Conclusions:

    • The field requires more robust clinical trials, particularly dose-response studies, to advance dysphagia treatment.
    • Addressing clinical pressures and facilitating research are essential for improving patient outcomes.
    • The Communications Sciences and Disorders Clinical Trials Research Group (CSDRG) is available to support clinical trial development in dysphagia.

    More Related Videos

    Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing07:45

    Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

    Published on: December 1, 2023

    Related Concept Videos

    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

    Gastroesophageal Reflux Disease II: Clinical Features and Management

    Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
    Clinical Manifestations
    GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
    Esophageal Strictures-II: Clinical Features and Management01:26

    Esophageal Strictures-II: Clinical Features and Management

    Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
    Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

    Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

    PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
    Barrett Esophagus-II: Clinical Manifestations and Management01:21

    Barrett Esophagus-II: Clinical Manifestations and Management

    Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
    To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...